Isomorphic Labs, the four-year old drug discovery start-up owned by Google parent Alphabet, will have an artificial intelligence-designed drug in trials by the end of this year, says its founder Sir Demis Hassabis.
Isomorphic Labs是谷歌母公司Alphabet旗下成立四年的新药研发公司，其创始人德米斯•哈萨比斯爵士(Sir Demis Hassabis)表示，到今年年底，该公司将有一款人工智能设计的药物进入试验阶段。
您已阅读10%（323字），剩余90%（2979字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。